• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Singapore·Healthcare·8357.HK
Share

Republic Healthcare Limited Stocks

HK$ 0.24Last Updated 26.10.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

HK$ 15.76M

HK$ 0.24
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Republic Healthcare Limited, a Singaporean primary healthcare enterprise, furnishes an array of medical services, encompassing consultations, diagnostic examinations, and therapeutic interventions. The company delivers diverse treatment solutions for prevalent health issues, specifically prioritizing sexual health and infectious diseases. Furthermore, it provides remedies for common dermatological ailments and basic medical aesthetics. The organization manages ten clinics in total: nine branded as Dr. Tan & Partners, alongside a single S Aesthetics clinic. Founded in 2010, Republic Healthcare Limited conducts its operations from its headquarters situated in Singapore.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

27.10.2026 02:47

Investors' appetite for risk has returned: AI sector stocks started the week on an upswing

27.10.2026 01:51

Anthropic reveals dependence on Google, Amazon, and Microsoft ahead of IPO

27.10.2026 00:38

Microsoft is cutting costs: 60,000 employees have been offered voluntary separation

27.10.2026 00:18

‘It’ll likely start as a credit event’: How neocloud woes threaten the S&P 500

26.10.2026 23:40

Buyers of the foldable iPhone have complained about screen damage. How does this affect the stock price?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026